EGFR-IN-32
EGFR-IN-32 is a potent inhibitor of EGFR. Overexpression and mutation of the epidermal growth factor receptor (EGFR) has been clearly demonstrated to lead to uncontrollable cell growth and is associated with the progression of most cancer diseases, especially NSCLC. EGFR-IN-32 has the potential for the research of diseases associated with EGFR mutations (extracted from patent WO2021185297A1, compound 2).
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2701553-78-6
- Fòrmula: C31H34N6O3
- Peso molecular:538.64
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Ver todos los productos específicos de isoformas EGFR
More
Actividad biológica
Chemical Information
-
No. CAS 2701553-78-6
-
Peso molecular 538.64
-
Fòrmula C31H34N6O3
-
SMILES
O=C(NC1=CC(NC2=NC=CC(C3=C(OC4=CC=CC=C4)C=CC=C3)=N2)=C(C=C1N(CCN(C)C)C)OC)C=C
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
EGFR-IN-32 Related Classifications
HY-144049 Related Classifications
Powered by Bioz